A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes

NCT04017832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1441

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Oral semaglutide
DRUG: Sitagliptin
DRUG: Placebo (oral semaglutide)
DRUG: Placebo (sitagliptin)

Sponsor

Novo Nordisk A/S